Saskatchewan Tenders #ACAN-SHA20260805

Procurement of Illumina NextSeq 2000 Sequencing System and Services for SHA Genomics Lab

The Saskatchewan Health Authority (SHA) is planning to award a contract for advanced genomic sequencing technology and related services at the Royal University Hospital Lab in Saskatoon. - Government Buyer: - Saskatchewan Health Authority (SHA), Genomics Division of Laboratory Medicine, Royal University Hospital Lab, Saskatoon - OEM Highlight: - Illumina Inc. is the sole named Original Equipment Manufacturer (OEM) - Products and Quantities: - Illumina NextSeq 2000 Sequencing Equipment (1 unit) - Part number: NextSeq 2000 - Supports whole exome and genome sequencing, high-throughput clinical genetic testing, and multiple flow cell types - Must be compatible with SOPHiA Genetics reagents and software - Services: - 24/7 technical support and rapid service response (within 24 hours of troubleshooting call) - Training for staff to operate and maintain the equipment - Unique/Notable Requirements: - Equipment must enable seamless transition from existing MiSeq systems - Must meet stringent technical, operational, environmental, and safety standards - Compatibility with SOPHiA Genetics assays, SOPHiA DDM, and Alamut software is mandatory - Designed for high-throughput and a broad range of genomic applications - Contract Details: - Five-year base term with options for two additional one-year extensions - Other suppliers may submit statements of capabilities if they can meet all requirements

Description

The Saskatchewan Health Authority (SHA) intends to award a contract for a five-year term, with options to extend for two additional one-year terms, for Next-Generation Sequencing (NGS) Equipment, its services, and consumables at the Royal University Hospital Lab in Saskatoon. The contract is proposed to be awarded to Illumina Inc. However, other suppliers are invited to submit statements of capabilities by August 31, 2026, to demonstrate their ability to meet the requirements. If other capable suppliers are identified, a further competitive process may be conducted. The equipment must support a broad range of genomic applications, be compatible with existing assays and software, and meet specific technical and operational criteria.

View original listing